|
DNAJB4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.182100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.049400E-01 |
| Normal-vs-Stage2 |
6.010800E-01 |
| Normal-vs-Stage3 |
6.36709999999319E-05 |
| Normal-vs-Stage4 |
4.415800E-03 |
| Stage1-vs-Stage2 |
7.295200E-01 |
| Stage1-vs-Stage3 |
1.123520E-03 |
| Stage1-vs-Stage4 |
1.355660E-02 |
| Stage2-vs-Stage3 |
1.304980E-01 |
| Stage2-vs-Stage4 |
1.522000E-01 |
| Stage3-vs-Stage4 |
9.793000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.096300E-02 |
| Normal-vs-AfricanAmerican |
5.904700E-03 |
| Normal-vs-Asian |
8.639400E-01 |
| Caucasian-vs-AfricanAmerican |
1.104780E-01 |
| Caucasian-vs-Asian |
6.665000E-01 |
| AfricanAmerican-vs-Asian |
1.928810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.534400E-02 |
| Normal-vs-Female |
1.661030E-01 |
| Male-vs-Female |
4.543400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.207770E-01 |
| Normal-vs-Age(41-60Yrs) |
2.798800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.959100E-04 |
| Normal-vs-Age(81-100Yrs) |
6.563600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.434200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.893400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.410200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.503700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.657600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.317200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.436390E-01 |
| Normal-vs-Grade 2 |
9.421400E-01 |
| Normal-vs-Grade 3 |
2.373900E-02 |
| Normal-vs-Grade 4 |
1.758020E-03 |
| Grade 1-vs-Grade 2 |
3.408000E-01 |
| Grade 1-vs-Grade 3 |
3.596000E-02 |
| Grade 1-vs-Grade 4 |
2.120000E-02 |
| Grade 2-vs-Grade 3 |
2.843900E-02 |
| Grade 2-vs-Grade 4 |
1.462210E-03 |
| Grade 3-vs-Grade 4 |
2.566600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.136180E-01 |
| Normal-vs-ccB subtype |
1.16999999999479E-06 |
| ccA subtype-vs-ccB subtype |
2.8953999997583E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.878500E-02 |
| Normal-vs-N1 |
3.76060000000233E-05 |
| N0-vs-N1 |
5.618900E-03 |
|
|
